Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Finasteride and low-level laser therapy are similarly effective for frontal pattern hair loss.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

New treatments for male hypogonadism are effective and should be personalized.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Obese women with PCOS are more likely to have fatty liver disease.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that more research is needed to fully understand the causes of PCOS.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

We need better treatments for hair loss, and while test-tube methods are helpful, they can't fully replace animal tests for evaluating new hair growth treatments.

Finger length ratio may indicate male hair loss.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.